PD-L1 expression on cancer cells and tumor-infiltrating immune cells can also be induced by local inflammation, i.e., type I/II IFN-gamma released by activated T cells, a condition termed “adaptive immune resistance” (Figure 2C) (153). This evidence concerns the gene IFNG and cancer.